Hera will be located at booth 1103 of the SOT ToxExpo in New Orleans March 14-16. Visit us to learn about utilizing gene editing to develop more predictive and high throughput in vitro and in vivo models, requiring less reliance on traditional animal models. Hera is working to develop better in vitro models of neurotoxicity, hepatotoxicity and off target hormonal effects with high throughput reporter cell lines.  On the in vivo side, Hera is developing humanized liver and immune system rat models for hepatotoxicity, cancer xenograft, DDI, and immunogenicity testing.